New award for oseltamivir phosphate capsules and suspension with exelan. Period of performance 2-22-2024 - 2-21-2025.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79724D0012
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Oseltamivir (VA-24-00009464) Pre-Solicitation · 36E79723R0039 · Posted Sep 29, 2023
- Last date to order 90% complete
- IDV ceiling
- $10,164,262.95
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for oseltamivir phosphate capsules and suspension on February 22, 2024, with a ceiling of $10,164,262.95 and an ultimate completion date of February 21, 2027.
The contract carries no set-aside designation and is structured as a requirements contract. Place of performance includes Exelan's primary facility in Boca Raton, Florida, and secondary locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and designated federal delivery points.
The originating solicitation (36E79723R0039) sought uninterrupted supply of oseltamivir in 30 mg, 45 mg, and 75 mg capsule quantities totaling over 100 million annually, plus over 34,000 bottles of 6 mg/ml suspension per year, for distribution to VA, DOD, BOP, and IHS customers. The contract carries NAICS code 325412 and PSC code 6505.
The period of performance runs from February 22, 2024, through February 21, 2025, with four successive one-year option periods. A modification to the contract deleted a line item without altering the contract's scope. Recent delivery activity under related work includes a $74.1 million delivery order from the Office of the Assistant Secretary for Preparedness and Response for oseltamivir phosphate capsules awarded June 28, 2025.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract 36E79724D0012?
36E79724D0012 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on February 22, 2024.
How much is contract 36E79724D0012 worth?
36E79724D0012's own ceiling is $10,164,263.
Who can order from contract 36E79724D0012?
36E79724D0012 is a single award indefinite delivery contract.
Was contract 36E79724D0012 competed?
The extent of competition for 36E79724D0012 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV